Dr. Maite Del Carmen Talbott, MD

Dr. Talbott practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Talbott's NPI, 1184615692, was assigned on November 3, 2005. Dr. Talbott graduated from University of Zulia in 1993. Dr. Talbott holds New York license 234665.

Dr. Talbott's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Talbott also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Talbott's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Talbott is also affiliated with Mount Sinai Beth Israel. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Talbott to 1 more hospital, 4 group practices and clinics, 4 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Talbott practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Talbott's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Talbott is board certified in neurology with special qualification in child neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Talbott's licenses on file in 2 states: New York and Florida.

CMS data shows 16 Medicare services from Dr. Talbott across 1 procedure code in 2021, for 13 Medicare patients. Medicare paid $840 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 13 Medicare patients who saw Dr. Talbott in 2024. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Talbott's median patient age at 11, with 44% women.

In 2024, Dr. Talbott wrote 91 Medicare Part D claims. 87% of them were for generic drugs. CMS names the drug for 66 of them, across 4 drugs with 11 or more claims each, at $20,755 in total drug cost. In 2023, CMS named 71 claims across 6 drugs.

Dr. Talbott accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 346 general payments to Dr. Talbott from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Neurelis, Inc. paid the most, $21,417.

Dr. Talbott graduated from University of Zulia in 1993.

Dr. Talbott is in network with 13 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.